Annual Meeting

Ruppin synthesizes cross-field expertise to study synthetic lethality

He's won the ASBMB’s 2023 DeLano Award in Computational Biology
Laurel Oldach
Oct. 17, 2022

Eytan Ruppin says one of his favorite talks to deliver is not about his research: “The title of my talk is ‘How not to build a scientific career,’ all the mistakes I made — and I made plenty."

Eytan Ruppin
Eytan Ruppin

Ruppin followed an unusual path to cancer functional genomics research. After medical school, he earned a Ph.D. in computer science in parallel to clinical training in psychiatry. For 10 years, he led a computational neuroscience lab. But around 2005, he became convinced that the brain would never be understood in his lifetime, he said ironically, “I went into computational biology and easier problems — like how to solve cancer.”

By applying his expertise in predictive modeling to cancer metabolism, Ruppin came across synthetic lethality, a concept that has become important for cancer treatment. His work in this domain has earned him the American Society for Biochemistry and Molecular Biology’s 2023 DeLano Award in Computational Biology.

Nowadays, Ruppin’s lab uses insights into interactions between drug targets and cancer genomic events to try to predict how individual cancer patients will respond to specific treatments. Clinical trials using transcriptomic data from each patient’s tumor to make a personalized treatment plan are under development at the National Cancer Institute, run by a company Ruppin founded but has since divested from. Meanwhile the lab continues to work at fine-tuning its predictions.

Recently, researchers in the lab have explored using single-cell transcriptomics to improve predictions about treatment efficacy. But to speed up progress, Ruppin said, the field needs many more public cancer transcriptomes. Projects like The Cancer Genome Atlas, he said, are "a drop in the sea," and the field has far to go to improve data availability.

Moving slowly from triumph to treatment

Synthetic lethality is a pairwise relationship between two genes; when either of the two loses function, the cell can survive, but when both are lost together, the combined effect kills the cell. Cancer inactivates many genes, especially tumor suppressors, so targeting their synthetic lethal partners can selectively kill tumor cells and spare normal ones. Ruppin's lab seeks data-driven ways to identify and harness synthetically lethal gene pairs.

In 2011, studying a rare cancer driven by a tumor suppressor mutation, Ruppin’s and collaborator Eyal Gottlieb’s teams found that inhibiting a synthetic lethal partner of a major tumor suppressor in kidney cancer, an intervention that is normally harmless, killed the cells. They could survive the loss of either function alone, but not both.

“It was a kind of triumph for genome-scale metabolic modeling,” Ruppin said.

Moving to data-driven efforts, Ruppin's lab now looks for interactions across the whole genome of many cancers. With the increase in scale comes a loss in detail; the lab has little insight, Ruppin said, into the mechanisms by which synthetic lethal pairs interacts. Still, with experimental collaborators, they have identified potential treatments for uveal melanoma and pancreatic cancer that are now in clinical trials.

“This is just the beginning of a long journey,” Ruppin said.

2023 ASBMB award winners

Gira Bhabha: ASBMB Early-Career Leadership Award
Bhabha found creativity in hard science

Squire J. Booker: ASBMB–Merck Award / Ruth Kirschstein Diversity in Science Award
Booker catalyzes progress in science and outreach

Itay Budin: Walter A. Shaw Young Investigator Award in Lipid Research
Budin dives into the details

Russell DeBose-Boyd: Avanti Award in Lipids
DeBose–Boyd has a recipe for success

Scott Dixon: Earl and Thressa Stadtman Young Scholar Award
Dixon uncovers a new type of cell death

Catherine Drennan: William C. Rose Award
Drennan makes science fun and accessible

Anne Kenworthy: Mildred Cohn Award in Biological Chemistry
Kenworthy links quantity to theory

Keith Matthews: Alice and C.C. Wang Award in Molecular Parasitology
Matthews’ career-long search for truth

Kerry-Anne Rye: ASBMB Mid-Career Leadership Award
Rye offers tools for success

Regina Stevens-Truss: ASBMB Award for Exemplary Contributions to Education
K-12 to undergrad, Stevens–Truss helps all students

Erica Ollmann Saphire: Bert & Natalie Vallee Award in Biomedical Science
Saphire is on the forefront of antibody therapeutics

Ajit Varki: Herbert Tabor Research Award
Varki seeks clues in chimps, grandmothers and sialic acid

Dyann Wirth: Alice and C.C. Wang Award in Molecular Parasitology
Wirth focuses on parasitology and policy

Enjoy reading ASBMB Today?

Become a member to receive the print edition monthly and the digital edition weekly.

Learn more
Laurel Oldach

Laurel Oldach is a former science writer for the ASBMB.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

NAS elects new members
Member News

NAS elects new members

Sept. 25, 2023

The National Academy of Sciences recognized these ASBMB members for their distinguished and continued achievements in original scientific research.

In memoriam: Tadashi Inagami
In Memoriam

In memoriam: Tadashi Inagami

Sept. 25, 2023

He was an emeritus professor at Vanderbilt University known for his pioneering research into the causes of hypertension, heart failure and vascular disease.

Meet Sarah O’Connor

Meet Sarah O’Connor

Sept. 21, 2023

This JBC associate editor scouts the plant kingdom for intriguing pathways and hits the hiking trails in Germany.

Shedding light on Usher syndrome
Health Observance

Shedding light on Usher syndrome

Sept. 16, 2023

On this awareness day, learn about the most common cause of genetic deaf–blindness and those it affects.

Top-notch papers by postdocs

Top-notch papers by postdocs

Sept. 15, 2023

During National Postdoc Appreciation Week, learn about the postdoc first authors of the most-read papers in ASBMB’s journals.

Completing the cycle of genomic medicine
Health Observance

Completing the cycle of genomic medicine

Sept. 11, 2023

Wolfgang Pernice is both a patient with and a researcher of Charcot‒Marie‒Tooth disease.